An underground economy for unlicensed weight-loss medications is propelled by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Investigational Drug Gaining Popularity Via Social Media
The experimental drug, which remains in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Followers are encouraged to contact these profiles privately for supplier links, while also receiving promotional offers.
Active Commerce on Social Networks
Additionally, a robust trade exists on messaging services, where groups with thousands of participants share comparison images, administration instructions and assertions of next-day UK delivery. Sellers promote the drug there before redirecting customers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.
Healthcare Professionals Express Worries
However, physicians and pharmacists have warned that the sale of what is still an unapproved medication in the UK is a cause for concern and could result in users injecting products of uncertain source.
Some professionals stated the popularity for the experimental drug could be linked to the rising price of licensed slimming products such as Mounjaro.
Legal Position and Enforcement
Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that cannot be promoted or supplied for human use under the British medical regulations.
Several influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, advertising, and customer regulations, risking fines, prosecution or imprisonment.
Service Response and Content Removal
According to TikTok, the platform has removed violative material and prohibited related hashtags and query recommendations. The company said it was dedicated to maintaining the platform secure and investing in strengthening compliance measures.
Digital Trading Activities
Research also discovered communities with up to 9,000 members selling the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, populated with images of weight loss, glowing testimonials and step-by-step guides for preparing or injecting at residence.
Within moments of entering one group, a vendor posted WhatsApp details, where the majority of transactions occur. The vendor sent an instruction manual and guaranteed shipping within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about weight, medical conditions or past usage.
Product Information and Costs
Within these communities, posts show dark colored parcels with postal service stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with sterile water, or pre-filled pens typically sold at £160 for 20mg. When asked how long a injector should be used, sellers give contradictory answers varying between a several days to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for the messaging service said it actively monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering substances they cannot confirm. Although the science behind this drug is sound, these online versions may not include what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
A medical professional of an online medical service linked the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, individuals are using social media. But fake treatments are extremely risky. You cannot know what’s inside or whether the environment they were produced in was sterile,” she explained.
Her team has already seen individuals injured by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be impure or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly said the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose patients to possibly significant health risks”.
